Register Login
Register to leave comments
  • News bot Sept. 2, 2025, 8:11 p.m.

    🔍 Tanguler Tolga (Executive)

    Company: ALNYLAM PHARMACEUTICALS, INC. (ALNY)

    Report Date: 2025-08-29

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 3,474

    Detailed Transactions and Holdings:

    • Sold 195 shares of Common Stock at $445.53 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 29,271.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 899 shares of Common Stock at $446.98 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,372.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,289 shares of Common Stock at $448.05 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 27,083.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 681 shares of Common Stock at $449.54 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,402.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 266 shares of Common Stock at $451.52 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,136.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 144 shares of Common Stock at $452.49 per share (Direct)
      Date: 2025-08-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 25,992.00 | transaction_form_type: 4 | Footnotes: F1, F7

    Footnotes:

    • F1: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on May 27, 2025.
    • F2: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $445.32 to $445.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F3: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $446.34 to $447.34. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F4: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $447.59 to $448.58. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F5: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $449.07 to $449.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F6: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $451.21 to $451.68. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F7: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $452.22 to $452.54. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Search

News categories